Bisindoylmaleimide I suppresses adipocyte differentiation through stabilization of intracellular β-catenin protein

Biochemical and Biophysical Research Communications

Volumn 367, Issue 1, 2008, Pages 195-200

  Cho, Munju ^a   Park, Seoyoung ^a   Gwak, Jungsug ^a   Kim, Dong Eun ^b   Yea, Sung Su ^a   Shin, Jae Gook ^a   Oh, Sangtaek ^a  

^a Inje University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

3T3 L1 preadipocytes; Adipogenesis; BIM; C EBP ; PPAR ; Wnt catenin signaling pathway

Indexed keywords

BETA CATENIN; BINDING PROTEIN; BISINDOYLMALEIMIDE I; LIPID; MALEIMIDE DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PROTEIN KINASE C; UNCLASSIFIED DRUG; WNT PROTEIN;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HEK293; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID STORAGE; PRIORITY JOURNAL; PROADIPOCYTE; PROTEIN STABILITY; UPREGULATION;

3T3-L1 CELLS; ADIPOCYTES; ADIPOGENESIS; ANIMALS; BASE SEQUENCE; BETA CATENIN; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; CELLS, CULTURED; ENZYME INHIBITORS; INDOLES; MALEIMIDES; MICE; PPAR GAMMA; PROTEIN KINASE C; WNT PROTEINS;

MUS;

EID: 38049018472     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2007.12.147     Document Type: Article

References (37)

1. Spiegelman B.M., and Flier J.S. Adipogenesis and obesity: rounding out the big picture. Cell 87 (1997) 212-218
2. MacDougald O.A., and Mandrup S. Adipogenesis: forces that tip the scales. Trends Endocrionol. Metab. 13 (2002) 5-11
3. Rangwala S.M., and Lazar M.A. Transcriptional control of adipogenesis. Annu. Rev. Nutr. 20 (2000) 535-559
4. Rosen E.D., and Spiegelman B.M. Molecular regulation of adipogenesis. Annu. Rev. Cell Dev. Biol. 16 (2000) 145-171
5. Rosen E.D., Walkey C.J., Puigserver P., and Spiegelman B.M. Transcriptional regulation of adipogenesis. Genes Dev. 14 (2000) 1293-1307
6. Brun R.P., Kim J.B., Hu E., and Spiegelman B.M. Peroxisome proliferators-activated receptor gamma and the control of adipogenesis. Curr. Opin. Lipidol. 8 (1977) 212-218
7. Christy R.J., Kaestner K.H., Geiman D.E., and Lane M.D. CCAAT/enhancer binding protein gene promoter: binding of nuclear factors during differentiation of 3T3-L1 preadipocytes. Proc. Natl. Acad. Sci. USA 88 (1991) 2593-2597
8. Wodarz A., and Nusse R. Mechanisms of Wnt signaling in development. Annu. Rev. Cell Dev. Biol. 14 (1998) 59-88
9. Polakis P. Wnt signaling and cancer. Genes Dev. 14 (2000) 1837-1851
10. Giles R.H., vsn Es J.H., and Clevers H. Caught up in a Wnt storm: Wnt signaling in cancer. Biochim. Biophys. Acta 1653 (2003) 1-24
11. 2+ pathway: a new vertebrate Wnt signaling pathway takes shape. Trends Genet. 16 (2000) 279-283
12. Winklbauer R., Medina A., Swain R.K., and Steinbeisser H. Frizzled-7 signalling controls tissue separation during Xenopus gastrulation. Nature 413 (2001) 856-860
13. Liu C., Li Y., Semenov M., Han C., Baeg G.H., Tan Y., Zhang Z., Lin X., and He X. Control of β-catenin phosphorylation/degradation by a dual-kinase mechanism. Cell 108 (2002) 837-847
14. Lee E., Salic A., Kruger R., Heinrich R., and Kirschner M.W. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway. PLoS Biol. 1 (2003) 116-132
15. Tetsu O., and McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398 (1999) 422-426
16. He T.C., Sparks A.B., Rago C., Hermeking H., Zawel L., da Costa L.T., Morin P.J., Vogelstein B., and Kinzler K.W. Identification of c-MYC as a target of the APC pathway. Science 281 (1998) 1509-1512
17. Takahashi M., Tsunoda T., Seiki M., Nakamura Y., and Furukawa Y. Identification of membrane-type metrix metalloproteinase-7 as a target of the β-catenin/TCF-4 complex in human colorectal cancers. Oncogene 21 (2002) 5861-5867
18. He T.C., Chan T.A., Vogelstein B., and Kinzler K.W. PPARδ is an APC-regulated target of nonsteroidal anti-inflammatory drugs. Cell 99 (1999) 335-345
19. Bennett C.N., Hodge C.L., MacDougald O.A., and Schwartz J. Role of Wnt 10b and C/EBPα in spontaneous adipogenesis of 243 cells. Biochem. Biophys. Res. Commun. 302 (2003) 12-16
20. Christodoulides C., Laudes M., Cawthorn W.P., Schinner S., Soos M., O'Rahilly S., Sethi J.K., and Vidal-Puig A. The Wnt antagonist Dickkopf-1 and its receptors are coordinately regulated during early human adipogenesis. J. Cell Sci. 119 (2006) 2613-2620
21. Ross S.E., Hemati N., Longo K.A., Bennett C.N., Lucas P.C., Erickson R.L., and MacDougald O.A. Inhibition of adipogenesis by Wnt signaling. Science 289 (2000) 950-953
22. Bennett C.N., Ross S.E., Longo K.A., Bajnok L., Hemati N., Jhonson K.W., Harrison S.D., and MacDougald O.A. Regulation of Wnt signaling during adipogenesis. J. Biol. Chem. 277 (2002) 30998-31004
23. Park S., Gwak J., Cho M., Song T., Won J., Kim D.E., Shin J.G., and Oh S. Hexachlorophene inhibits Wnt/β-catenin pathway by promoting Siah-mediated β-catenin degradation. Mol. Pharmacol. 70 (2006) 960-966
24. Dignam J.D., Lebovitz R.M., and Roeder R.G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11 (1983) 1475-1489
25. Song G.Y., Lee J.H., Cho M., Park B.S., Kim D.E., and Oh S. Decursin suppresses human androgen-independent PC3 prostate cancer cell proliferation by promoting the degradation of β-catenin. Mol. Pharmacol. 72 (2007) 1599-1606
26. Gwak J., Cho M., Gong S.J., Won J., Kim D.E., Kim E.Y., Lee S.S., Kim M., Kim T.K., Shin J.G., and Oh S. Protein-kinase-C-mediated β-catenin phosphorylation negatively regulates the Wnt/β-catenin pathway. J. Cell Sci. 119 (2006) 4702-4709
27. Hart M.J., del los Santos R., Albert I.N., Rubinfeld B., and Polakis P. Downregulation of β-catenin by human Axin and its association with the APC tumor suppressor, β-catenin and GSK3β. Curr. Biol. 8 (1998) 573-581
28. Aberle H., Bauer A., Stappert J., Kispert A., and Kemler R. β-Catenin is a target for the ubiquitin-proteasome pathway. EMBO J. 16 (1997) 3797-3804
29. Liu J., Stevens J., Rote C.A., Yost H.J., Hu Y., Neufeld K.L., White R.L., and Matsunami N. Siah-1 mediates a novel β-catenin degradation pathway linking p53 to the adenomatous polyposis coli protein. Mol. Cell 7 (2001) 927-936
30. Clemens M.J., Trayner I., and Menaya J. The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. J. Cell Sci. 103 (1992) 881-887
31. Gallicano G.I., Yousef M.C., and Capco D.G. PKC-a pivotal regulator of early development. Bioassay 19 (1997) 29-36
32. McCarty M.F. Up-regulation of intracellular signaling pathways may play a central pathogenic role in hypertension, atherogenesis, insulin-resistance and cancer promotion-the 'PKC syndrome'. Med. Hypotheses 46 (1996) 113-120
33. Flemings I., MacKenzie S.J., Vernon R.G., Anderson N.G., Houslay M.D., and Kilgour E. Protein kinase C isoforms play differential roles in the regulation of adipocyte differentiation. Biochem. J. 333 (1998) 719-727
34. Lacasa D., Agli B., and Giudicelli Y. Zeta PKC in rat preadipocytes: modulation by insulin and serum mitogenic factors and possible role in adipogenesis. Biochem. Biophys. Res. Commun. 217 (1995) 123-130
35. Zhou Y., Wang D., Li F., Shi J., and Song J. Different roles of protein kinase C-b1 and d in the regulation of adipocyte differentiation. Int. J. Biochem. Cell Biol. 38 (2006) 2151-2163
36. Christodoulides C., Scarda A., Granzotto M., Milan G., Dalla Nora E., Keogh J., De perogola G., Stirling H., Pannacciulli N., Sethi J.K., Federspil G., Vidal-Puig I., Farooqi I.S., O'Rahilly S., and Vettor R. Wnt10b mutations in human obesity. Diabetologia 49 (2006) 678-684
37. Guo Y.D., Xiong H., Shen H., Zhao I., Xiao P., Guo Y., Wang W., Yang T., Robert R., and Deng H. Polymorphism of the low-density lipoprotein receptor-related protein 5 (LRP5) gene are associated with obesity phenotype in a large family-based association study. J. Med. Genet. 43 (2006) 798-803